Stonepine Capital Management, LLC Portfolio Holdings

Stonepine Capital Management, LLC

  • $102 Billion
  • Q2 2025

Stonepine Capital Management, LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $102 Billion distributed in 59 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $13.7B, Evolus, Inc. with a value of $8.44B, Kempharm, Inc with a value of $6.83B, Verastem Inc with a value of $5.65B, and Indivior PLC with a value of $5.16B.

Examining the 13F form we can see an decrease of $835M in the current position value, from $103B to 102B.

Stonepine Capital Management, LLC is based out at Bend, OR

Below you can find more details about Stonepine Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $102 Billion
Healthcare: $78 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.29B
$13.7 Billion 13.4% of portfolio
750,000
Q2 2025 Reduced 7.41%
$359M
$8.44 Billion 8.28% of portfolio
916,500
Q2 2025 Reduced 19.22%
$170M
$6.83 Billion 6.7% of portfolio
775,620
Q2 2025 Added 19.33%
Verastem Inc
-
$5.65 Billion 5.54% of portfolio
-
Q2 2025 Added 121.92%
Indivior PLC
-
$5.16 Billion 5.06% of portfolio
-
Q2 2025 Added 15.13%
$4.12B
$4.85 Billion 4.76% of portfolio
225,000
Q2 2025 Added 140.92%
$142M
$4.57 Billion 4.48% of portfolio
604,066
Q2 2025 Added 2.26%
$30.7M
$4.04 Billion 3.97% of portfolio
2,083,762
Q2 2025 Added 1.39%
$326M
$3.83 Billion 3.76% of portfolio
152,143
Q2 2025 Added 17.2%
$359M
$3.09 Billion 3.03% of portfolio
310,033
Q2 2025 Added 181.85%
$451M
$2.93 Billion 2.87% of portfolio
450,000
Q2 2025 Added 29.01%
Surrozen Inc
-
$2.74 Billion 2.68% of portfolio
-
Q2 2025 Added 7.08%
$1.54B
$2.52 Billion 2.47% of portfolio
38,597
Q2 2025 Reduced 19.59%
$866M
$2.18 Billion 2.13% of portfolio
555,000
Q2 2025 New
$127M
$2.02 Billion 1.98% of portfolio
190,590
Q2 2025 Reduced 7.77%
Aytu Biopharma Inc
-
$1.77 Billion 1.74% of portfolio
-
Q2 2025 Added 75.25%
$510M
$1.41 Billion 1.38% of portfolio
1,000,000
Q2 2025 Added 100.0%
$156M
$1.36 Billion 1.34% of portfolio
657,380
Q2 2025 Reduced 17.42%
Nektar Therapeutics
-
$1.3 Billion 1.27% of portfolio
-
Q2 2025 New
$372M
$1.29 Billion 1.26% of portfolio
285,300
Q2 2025 Added 117.52%
$1.29B
$1.23 Billion 1.2% of portfolio
41,500
Q2 2025 Added 101.39%
$244M
$1.18 Billion 1.16% of portfolio
250,000
Q2 2025 Added 611.28%
$301M
$1.13 Billion 1.11% of portfolio
100,000
Q2 2025 Added 364.04%
Alumis Inc
-
$1.05 Billion 1.03% of portfolio
-
Q2 2025 New
$7.84M
$988 Million 0.97% of portfolio
457,419
Q2 2025 Added 65.31%
$241M
$977 Million 0.96% of portfolio
219,000
Q2 2025 New
$992M
$958 Million 0.94% of portfolio
205,100
Q2 2025 Added 100.56%
$64.8M
$897 Million 0.88% of portfolio
845,968
Q2 2025 Added 34.24%
$734M
$870 Million 0.85% of portfolio
92,900
Q2 2025 New
Grace Therapeutics Inc
-
$869 Million 0.85% of portfolio
-
Q2 2025 Reduced 0.7%
Kezar Life Sciences Inc
-
$778 Million 0.76% of portfolio
-
Q2 2025 Added 69.86%
$346M
$765 Million 0.75% of portfolio
77,141
Q2 2025 New
Achieve Life Sciences Inc
-
$753 Million 0.74% of portfolio
-
Q2 2025 New
$109M
$698 Million 0.68% of portfolio
491,300
Q2 2025 Reduced 6.92%
$578M
$655 Million 0.64% of portfolio
130,000
Q2 2025 Reduced 10.11%
Bioage Labs Inc
-
$624 Million 0.61% of portfolio
-
Q2 2025 Added 202.17%
$1.55B
$623 Million 0.61% of portfolio
50,000
Q2 2025 New
$20.6M
$577 Million 0.57% of portfolio
544,494
Q2 2025 New
Kiora Pharmaceuticals Inc
-
$513 Million 0.5% of portfolio
-
Q2 2025 Reduced 11.29%
$82.8M
$455 Million 0.45% of portfolio
156,888
Q2 2025 New
Theratechnologies Inc
-
$446 Million 0.44% of portfolio
-
Q2 2025 Added 632.05%
$69.5M
$450 Million 0.44% of portfolio
226,009
Q2 2025 Reduced 5.42%
$164M
$377 Million 0.37% of portfolio
100,000
Q2 2025 New
$59.3M
$378 Million 0.37% of portfolio
145,900
Q2 2025 New
$816M
$299 Million 0.29% of portfolio
7,000
Q2 2025 Reduced 90.6%
$1.34B
$298 Million 0.29% of portfolio
30,000
Q2 2025 New
$38M
$256 Million 0.25% of portfolio
45,000
Q2 2025 New
$294M
$194 Million 0.19% of portfolio
85,000
Q2 2025 Added 192.31%
In8 Bio Inc
-
$172 Million 0.17% of portfolio
-
Q2 2025 New

Summary

  • Portfolio
  • No. of Stocks 59
  • Current Value $102 Billion
  • Prior Value $103 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 20 stocks
  • Additional Purchases 24 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email